MA39110B1 - Nouveau composé pour le traitement de l'hypoglycémie grave - Google Patents

Nouveau composé pour le traitement de l'hypoglycémie grave

Info

Publication number
MA39110B1
MA39110B1 MA39110A MA39110A MA39110B1 MA 39110 B1 MA39110 B1 MA 39110B1 MA 39110 A MA39110 A MA 39110A MA 39110 A MA39110 A MA 39110A MA 39110 B1 MA39110 B1 MA 39110B1
Authority
MA
Morocco
Prior art keywords
treatment
new compound
severe hypoglycemia
hypoglycemia
severe
Prior art date
Application number
MA39110A
Other languages
English (en)
Other versions
MA39110A1 (fr
Inventor
Jorge Alsina-Fernandez
Robert Chadwick Cummins
Lili Guo
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52273565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA39110(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA39110A1 publication Critical patent/MA39110A1/fr
Publication of MA39110B1 publication Critical patent/MA39110B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

La présente invention concerne un nouveau composé utile dans le traitement de l'hypoglycémie.
MA39110A 2013-12-18 2014-12-11 Nouveau composé pour le traitement de l'hypoglycémie grave MA39110B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917716P 2013-12-18 2013-12-18
PCT/US2014/069644 WO2015094876A1 (fr) 2013-12-18 2014-12-11 Nouveau composé pour le traitement de l'hypoglycémie grave

Publications (2)

Publication Number Publication Date
MA39110A1 MA39110A1 (fr) 2017-09-29
MA39110B1 true MA39110B1 (fr) 2018-04-30

Family

ID=52273565

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39110A MA39110B1 (fr) 2013-12-18 2014-12-11 Nouveau composé pour le traitement de l'hypoglycémie grave

Country Status (22)

Country Link
US (1) US20160311882A1 (fr)
EP (1) EP3083667A1 (fr)
KR (1) KR20160075826A (fr)
CN (1) CN105829340A (fr)
AP (1) AP2016009267A0 (fr)
AR (1) AR098615A1 (fr)
AU (1) AU2014366425B2 (fr)
BR (1) BR112016010635A2 (fr)
CA (1) CA2930596A1 (fr)
CR (1) CR20160227A (fr)
DO (1) DOP2016000142A (fr)
EA (1) EA201690966A1 (fr)
HK (1) HK1224305A1 (fr)
IL (1) IL245491A0 (fr)
MA (1) MA39110B1 (fr)
MX (1) MX2016007988A (fr)
PE (1) PE20160847A1 (fr)
PH (1) PH12016501183A1 (fr)
SG (1) SG11201604237PA (fr)
TN (1) TN2016000208A1 (fr)
TW (1) TW201609128A (fr)
WO (1) WO2015094876A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622596B (zh) 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
WO2019140024A1 (fr) 2018-01-12 2019-07-18 Eli Lilly And Company Polythérapie
CA3128922A1 (fr) 2019-02-05 2020-08-13 Eli Lilly And Company Agonistes analogiques du glucagon et leurs procedes d'utilisation
JP7712210B2 (ja) 2019-04-01 2025-07-23 ノヴォ ノルディスク アー／エス リラグルチドに対する抗体およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101578102B (zh) 2007-01-05 2013-07-17 印第安纳大学研究及科技有限公司 在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
WO2009099763A1 (fr) * 2008-01-30 2009-08-13 Indiana University Research And Technology Corporation Promédicaments peptidiques à base d’esters
TWI541023B (zh) * 2008-06-17 2016-07-11 印第安納大學科技研究公司 在生理ｐｈ緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
US8703701B2 (en) * 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
UA126465C2 (uk) * 2011-06-10 2022-10-12 Ханмі Сайенс Ко., Лтд. Пептид, що має активність оксинтомодуліну, та фармацевтична композиція для лікування ожиріння, яка його містить
EP2729493B1 (fr) * 2011-07-04 2020-06-10 IP2IPO Innovations Limited Nouveaux composés et leurs effets sur le comportement alimentaire

Also Published As

Publication number Publication date
EP3083667A1 (fr) 2016-10-26
CA2930596A1 (fr) 2015-06-25
HK1224305A1 (zh) 2017-08-18
KR20160075826A (ko) 2016-06-29
AU2014366425B2 (en) 2016-12-08
MX2016007988A (es) 2016-09-09
SG11201604237PA (en) 2016-07-28
IL245491A0 (en) 2016-06-30
CN105829340A (zh) 2016-08-03
PE20160847A1 (es) 2016-09-10
PH12016501183A1 (en) 2016-07-25
TN2016000208A1 (en) 2017-10-06
CR20160227A (es) 2016-07-12
WO2015094876A1 (fr) 2015-06-25
BR112016010635A2 (pt) 2017-12-05
AU2014366425A1 (en) 2016-05-26
EA201690966A1 (ru) 2016-12-30
DOP2016000142A (es) 2016-07-15
AR098615A1 (es) 2016-06-01
TW201609128A (zh) 2016-03-16
AP2016009267A0 (en) 2016-06-30
MA39110A1 (fr) 2017-09-29
US20160311882A1 (en) 2016-10-27

Similar Documents

Publication Publication Date Title
MA37740A1 (fr) Seringue
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
EA201491391A1 (ru) Терапевтически активные соединения и способы их применения
EA201500738A1 (ru) Способ получения замещенных оксиранов и триазолов
AR095097A1 (es) Compuestos de fenoxietoxi
EA201691983A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов cb2
CO7141429A2 (es) Nuevos compuestos de pirazol
EA201690763A1 (ru) Лечение рака поджелудочной железы
MA39110A1 (fr) Nouveau composé pour le traitement de l'hypoglycémie grave
MA39109B1 (fr) Nouveau composé pour le traitement de l'hypoglycémie grave
MA42166A1 (fr) Seringue
MA39108A1 (fr) Nouveau composé pour le traitement de l'hypoglycémie sévère
MA39019A1 (fr) Acétate de 4-{4-[(1e)-4-(2,9-diazaspiro[5.5]undéc-2-yl)but-1-én-1-yl]-2-méthylbenzyl}-5-(propan-2-yl)-1h-pyrazol-3-yl-bêta-d-glucopyranoside
EA201690214A1 (ru) Способ лечения гипертрофической кардиомиопатии
MA39432B1 (fr) Dérivé de tetrahydropyrrolo[3,4-d][1,3]thiazine en tant qu'inhibiteur de bace
EA201690593A1 (ru) Новые соединения мочевины
UA113753C2 (xx) Фенілзаміщені кетоеноли для боротьби з паразитами риб
MA38931B1 (fr) Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose
EA201600013A1 (ru) Основание ковша и ковш
MA38411A1 (fr) Inhibiteurs de cdc7